OncoSec Medical Inc (ONCSQ)

[chickpea598]

It is a fact that Amgen paid up to 1 Billion dollars to get their hands on T-Vec with the buyout of BioVet in 2011 so they could combine it with Yervoy and later with Keytruda. This was a huge bet on a belief in combination checkpoint therapy. The 1 billion dollar speculation on Oncosec is simply a comparison of what could be fetched for another therapy with similar response rates. Not out of the question at all and good to have a benchmark to compare to. Merck would not have to split money with Amgen if they took over Oncosec and have similar response rates.....a big money discount in my mind.